Tackling the challenges of nanomedicines: Are we ready?

Tackling the challenges of nanomedicines: Are we ready?

This review provides an overview of the proceedings of the symposium "Tackling the Challenges of Nanomedicines: Are We Ready?"organized by the International Pharmaceutical Federation (FIP) Hospital Pharmacy Section and Non-Biological Complex Drugs (NBCDs) Working Group at the 2019 FIP Worl...

Full description

Bibliographic Details
Main Authors: Di Francesco, T. (Author), Flühmann, B. (Author), Hertig, J.B (Author), Moss, R. (Author), Mühlebach, S. (Author), Shah, V.P (Author), Stemer, G. (Author), Surugue, J. (Author)
Format: Article
Language:English
Published: Oxford University Press 2021
Subjects:
Article
biosimilar agent
decision making
doxorubicin
drug efficacy
drug manufacture
drug safety
glatiramoid
hospital pharmacist
hospital pharmacy
human
Humans
iron saccharate
nanomedicine
Nanomedicine
nanosimilars
paclitaxel
pharmaceutical equivalence
pharmacists
pharmacy (discipline)
practice guideline
substitution
therapeutic equivalence
therapeutic equivalency
Therapeutic Equivalency
unclassified drug
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items